Compare INSP & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSP | TXG |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2018 | 2019 |
| Metric | INSP | TXG |
|---|---|---|
| Price | $53.32 | $20.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 15 |
| Target Price | ★ $94.00 | $20.25 |
| AVG Volume (30 Days) | 863.5K | ★ 2.4M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 179.43 | 76.97 |
| EPS | ★ 4.89 | N/A |
| Revenue | $82,050,000.00 | ★ $245,893,000.00 |
| Revenue This Year | $8.02 | N/A |
| Revenue Next Year | $8.11 | $7.33 |
| P/E Ratio | $11.28 | ★ N/A |
| Revenue Growth | 62.18 | ★ 68.06 |
| 52 Week Low | $48.30 | $7.72 |
| 52 Week High | $163.35 | $26.45 |
| Indicator | INSP | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 40.10 |
| Support Level | $52.37 | $11.66 |
| Resistance Level | $60.15 | $20.62 |
| Average True Range (ATR) | 2.74 | 1.40 |
| MACD | 0.18 | -0.50 |
| Stochastic Oscillator | 22.99 | 9.25 |
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).